Nano medicine applies nanoscale technologies to diagnose, treat, and prevent diseases, offering targeted delivery systems and improved therapeutic efficacy. Nanoparticles can enhance drug solubility, stability, and controlled release, reducing side effects and improving patient outcomes. Nanotechnology also plays a role in advanced imaging, biosensors, and regenerative medicine. Research in this field is expanding into personalized Nano medicine, cancer therapy, and antimicrobial treatments. Safety assessment, manufacturing scalability, and regulatory approval remain key considerations for clinical translation. The potential of Nano medicine lies in its ability to revolutionize diagnostics and therapies by working at the molecular and cellular levels.
subtracts:
Related Conferences:
World Congress on Pharmacology & Toxicology (WCPT) | International Conference on Clinical Pharmacology & Therapeutics (ICCPT) | Global Summit on Drug Discovery and Development (GSDDD) | European Conference on Toxicology & Applied Pharmacology (ECTAP) | International Symposium on Experimental and Clinical Toxicology (ISECT)
Related Associations:
International Union of Basic and Clinical Pharmacology (IUPHAR) | British Pharmacological Society (BPS) | American Society for Pharmacology and Experimental Therapeutics (ASPET) | European Society of Toxicology (EUROTOX) | Society of Toxicology (SOT) | Asia Pacific Association of Pharmacologists (APAP) | Federation of Asian Pharmacological Societies (FAPS) | International Society for the Study of Xenobiotics (ISSX)
All accepted abstracts will be published in respective Allied Academies Journals.
Abstracts will be provided with Digital Object Identifier by
